Canada’s leading prescription drug middleman is under investigation by federal anti-trust lawyers. The Competition Bureau in a Federal Court affidavit questioned the business practices of Express Scripts Canada Services of Mississauga, Ont.: ‘The inquiry is focused on alleged patient steering and margin squeezing.’
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
